Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.214NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.284ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.284ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.284ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.284NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.351.3 (Beta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.351.3 (Beta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.351.3 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.3 (Beta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.318ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.318ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.318ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.318NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
R.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
R.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
R.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
R.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.29 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.29 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.29 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.29 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ML.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ML.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ML.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ML.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.283ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.283ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.283ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.283NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.96ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.96ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.96ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.96NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
L.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
L.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
L.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
L.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.310ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.310ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.310ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.310NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.185ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used